| [1] |
Feng Y, Cai ZR, Tang Y, et al. TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells[J]. Genet Mol Res,2014,13(1):680-695.
|
| [2] |
Tan JHY, Canals M, Ludeman JP, et al. Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1)[J]. J Biol Chem,2012,287(18):14692-14702.
|
| [3] |
Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview[J]. J Interferon Cytokine Res,2009,29(6):313-326.
|
| [4] |
Kadomoto S, Izumi K, Mizokami A. Roles of CCL2-CCR2 axis in the tumor microenvironment[J]. Int J Mol Sci,2021,22(16):8530-8545.
|
| [5] |
陈婧，冯喜英，关巍, 等. 单核细胞趋化蛋白-1与肺部疾病关系的研究进展[J/CD]. 中华肺部疾病杂志(电子版),2017,5(10):601-603.
|
| [6] |
Zhang K, Luo J. Role of MCP-1 and CCR2 in alcohol neurotoxicity[J]. Pharmacol Res,2019,139:360-366.
|
| [7] |
Xu M, Wang Y, Xia R, et al. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting[J]. Cell Prolif,2021,54(10):e13115.
|
| [8] |
Wang Q, Ren J, Morgan S, et al. Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm[J]. PLoS One,2014,9(3):e92053.
|
| [9] |
Guo H, Pan C, Chang B, et al. Triptolide improves diabetic nephropathy by regulating Th cell balance and macrophage infiltration in rat models of diabetic nephropathy[J]. Exp Clin Endocrinol Diabetes,2016,124(6):389-398.
|
| [10] |
O’Connor T, Borsig L, Heikenwalder M. CCL2-CCR2 signaling in disease pathogenesis[J]. Endocr Metab Immune Disord Drug Targets,2015,15(2):105-108.
|
| [11] |
Akhter N, Wilson A, Thomas R, et al. ROS/TNF-α crosstalk triggers the expression of IL-8 and MCP-1 in human monocytic THP-1 cells via the NF-κB and ERK1/2 mediated signaling[J]. Int J Mol Sci,2021,22(19):10519.
|
| [12] |
王瑜，郑荣秀. 儿童脓毒症诊治研究进展[J]. 实用临床医药杂志,2021,25(14):118-122.
|
| [13] |
Murao A, Brenner M, Aziz M, et al. Exosomes in sepsis[J]. Front Immunol,2020(11):2140-2149.
|
| [14] |
Zhu TT, Liao XL, Feng T, et al. Plasma monocyte chemoattractant protein 1 as a predictive marker for sepsis prognosis a prospective cohort study[J]. Tohoku J Exp Med,2017,241(2):139-147.
|
| [15] |
许志平，马红玲，陈双峰, 等. MCP-1和mHLA-DR检测对脓毒症患者病情危重程度及预后评估的临床意义[J/CD]. 中华重症医学电子杂志(网络版),2019,5(3):225-229.
|
| [16] |
王珍，李国民，管双仙, 等. 血清降钙素原、N前端脑钠肽和APACHEⅡ评分预测脓毒症相关性脑病的价值[J]. 临床麻醉学杂志,2019,35(11):1047-1050.
|
| [17] |
闫禹，肖京，贾明雅, 等. 血清MCP-1, IL-6水平与脓毒性脑病患者脑损伤程度的关系[J]. 临床身心疾病杂志,2022,28(5):19-21.
|
| [18] |
Yoo H, Im Y, Ko R, et al. Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes[J]. Sci Rep,2021,11(1):9512-9521.
|
| [19] |
Hassuna NA, Elgezawy E, Mousa SO, et al. Diagnostic value of monocyte chemoattractant protein-1, soluble mannose receptor, presepsin, and procalcitonin in critically ill children admitted with suspected sepsis[J]. BMC Pediatr,2021,21(1):458-468.
|
| [20] |
于培儒. 单核细胞趋化蛋白-1在脓毒症患儿血浆中的表达及其对心肌损伤影响的初步研究[D]. 兰州大学,2011.
|
| [21] |
Yong KK, Chang JH, Chien MH, et al. Plasma monocyte chemoattractant protein-1 level as a predictor of the severity of community-acquired pneumonia[J]. Int J Mol Sci,2016,17(2):179-190.
|
| [22] |
廖汉杰，吴建武，阮金德. 小儿支原体肺炎患儿通气功能障碍发生的影响因素[J]. 右江医学,2021,49(11):857-860.
|
| [23] |
王雪燕. MIP-1α及MCP-1在沙眼衣原体肺感染小鼠中的表达及意义[J]. 河北医药,2019,41(3):425-427.
|
| [24] |
Brzozowska A, Majak P, Jerzynska J, et al. Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma[J]. Postepy Dermatol Alergol,2015,32(2):107-113.
|
| [25] |
Chira A, Braicu C, Budisan L, et al. Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome[J]. Exp Ther Med,2020,20(1):24-30.
|
| [26] |
吴开春，梁洁，冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志,2018,38(9):796-813.
|
| [27] |
Qiu S, Li P, Zhao H, et al. Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4 NF-κB signaling pathway[J]. Int Immunopharmacol,2020,78:106018.
|
| [28] |
杜鹏程，韩璠，谷九莲. 溃疡性结肠炎患者血清单核细胞趋化蛋白-1,高迁移率族蛋白B1,肿瘤坏死因子-α,白细胞介素-6和白细胞介素-10水平与肠道菌群的相关性[J]. 新乡医学院学报,2021,38(4):370-373.
|
| [29] |
Singh UP, Singh NP, Murphy EA, et al. Chemokine and cytokine levels in inflammatory bowel disease patients[J]. Cytokine,2016, 77:44-49.
|
| [30] |
Magnusson MK, Strid H, Isaksson S, et al. Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C[J]. J Crohns Colitis,2015,9(1):56-65.
|
| [31] |
Li YW, Yang CQ, Xiao YL, et al. The -A2518G polymorphism in the MCP-1 gene andinflammatory bowel disease risk: A meta-analysis[J]. J Dig Dis,2015,16(4):177-185.
|
| [32] |
Zannetti C, Roblot G, Charrier E, et al. Characterization of the inflammasome in human kupffer cells in response to synthetic agonists and pathogens[J]. J Immunol,2016,197(1):356-367.
|
| [33] |
李劲，骆仲榆，陈刘镇, 等. 慢性乙型肝炎病毒感染患者血清IL-33, sST2, MCP-1水平变化及其临床意义[J]. 中国医药导报,2019,16(17):125-128.
|
| [34] |
Yang J, Zhang H, Wang X, et al. Kruppel-like factor 10 protects against acute viral myocarditis by negatively regulating cardiac MCP-1 expression[J]. Cell Mol Immunol,2021,18(9):2236-2248.
|
| [35] |
Shen Y, Zhang FQ, Wei X. Truncated monocyte chemoattractant protein-1 can alleviate cardiac injury in mice with viral myocarditis via infiltration of mononuclear cells[J]. Microbiol Immunol,2014, 58(3):195-201.
|
| [36] |
胡安娜，刘春梅，杜自强, 等. 急性病毒性心肌炎小鼠肿瘤坏死因子-α,单核细胞趋化蛋白-1的表达及卡维地洛的干预作用[J]. 中华实用儿科临床杂志,2013,28(13):1020-1022.
|
| [37] |
蒋毅，齐文，熊小霞. 血清h-FABP, HMGB1和MCP-1对小儿病毒性心肌炎的诊断意义[J]. 临床和实验医学杂志,2022(13):1400-1404.
|
| [38] |
黄凯达，王仕海，朱庆华, 等. IL-6, IL-17, IL-18及MCP-1联合检测B型柯萨奇病毒性心肌炎的价值[J]. 中国实用医刊,2016,43(23):1-3.
|
| [39] |
Kirkley KS, Popichak KA, Afzali MF, et al. Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity[J]. J Neuroinflammation,2017,14(1):99-117.
|
| [40] |
Al-Obaidi M, Desa M. Mechanisms of blood brain barrier disruption by different types of bacteria, and bacterial-host interactions facilitate the bacterial pathogen invading the brain[J]. Cell Mol Neurobiol, 2018,38(7):1349-1368.
|
| [41] |
郑垒炬，朱晓波，白雁明, 等. 脑白质疏松症与血清单核细胞趋化因子-1的相关性分析[J]. 现代医药卫生,2017,33(12):1783-1784.
|
| [42] |
刘小壮. 流行性乙型脑炎患儿血清及脑脊液中MIP-1α, MCP-1, FKN, NSE水平与临床分型,分期的关系[J]. 临床医学研究与实践,2021,6(1):85-87.
|
| [43] |
王茜，王庆元，吉国强, 等. 流行性乙型脑炎患儿血清及脑脊液中MCP-1, FKN及其相关细胞因子的变化[J]. 海南医学院学报,2017,23(18):2535-2537.
|
| [44] |
张艳华，孔慧霞，张嘉雯, 等. 血清及脑脊液IL-1β, PCT, MCP-1水平变化在化脓性脑膜炎患儿病情评估及预后判断中的应用价值[J]. 中国临床实用医学,2017,3(8):45-47.
|
| [45] |
王倩云，彭晖，郑振华, 等. 蜱传脑炎病毒感染小鼠脑组织单核细胞趋化蛋白1 (MCP-1), CD68和核因子κB (NF-κB)表达增加[J]. 细胞与分子免疫学杂志,2020,36(1):9-13.
|
| [46] |
张静，李秀惠，李丽, 等. 手足口病病原学和流行病学研究进展[J]. 中华流行病学杂志,2022,43(5):771-783.
|
| [47] |
张玉凤，符佳，王军, 等. 205例手足口病合并惊厥患儿的病原学及临床特征[J/CD]. 中华实验和临床感染病杂志(电子版),2021,15(1):53-59.
|
| [48] |
陈小妮. 手足口病患儿外周血BMEC, RANTES, MCP-1表达水平及临床意义[J]. 内蒙古医学杂志,2021,53(6):737-738.
|
| [49] |
Wang SM, Lei HY, Liu CC. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis[J]. Clin Dev Immunol,2012, 2012:876241.
|
| [50] |
Jin Y, Zhang R, Wu W, et al. Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection[J]. Viruses, 2018,10(4):155-169.
|
| [51] |
Pei X, Fan X, Zhang H, et al. Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease[J]. Clin Exp Immunol,2019,196(3):353-363.
|
| [52] |
韩要强，朱东东，白振宇. 血清IL-17 IP-10 MCP-1在手足口病严重程度及预后评估中的价值[J]. 临床身心疾病杂志,2022,28(2):94-99.
|